HK1107263A1 - Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom - Google Patents

Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom

Info

Publication number
HK1107263A1
HK1107263A1 HK07113112.9A HK07113112A HK1107263A1 HK 1107263 A1 HK1107263 A1 HK 1107263A1 HK 07113112 A HK07113112 A HK 07113112A HK 1107263 A1 HK1107263 A1 HK 1107263A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
bradykinin antagonists
compositions therefrom
peptide bradykinin
peptide
Prior art date
Application number
HK07113112.9A
Other languages
English (en)
Inventor
Patrizia Felicetti
Christopher Ingo Fincham
Alessandro Giolitti
Carlo Alberto Maggi
Laura Quartara
Cristina Rossi
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of HK1107263A1 publication Critical patent/HK1107263A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK07113112.9A 2004-10-15 2007-11-30 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom HK1107263A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001963A ITMI20041963A1 (it) 2004-10-15 2004-10-15 "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
PCT/EP2005/010412 WO2006040004A1 (fr) 2004-10-15 2005-09-27 Antagonistes de bradykinine non-peptidiques et compositions pharmaceutiques constituees de ces composes

Publications (1)

Publication Number Publication Date
HK1107263A1 true HK1107263A1 (en) 2008-04-03

Family

ID=35810869

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113112.9A HK1107263A1 (en) 2004-10-15 2007-11-30 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom

Country Status (30)

Country Link
US (1) US7645759B2 (fr)
EP (1) EP1799214B8 (fr)
JP (1) JP4980917B2 (fr)
CN (1) CN101039671B (fr)
AR (1) AR051392A1 (fr)
AT (1) ATE381931T1 (fr)
AU (1) AU2005293881B2 (fr)
BR (1) BRPI0515983A (fr)
CA (1) CA2583920C (fr)
CY (1) CY1107254T1 (fr)
DE (1) DE602005004039T2 (fr)
DK (1) DK1799214T3 (fr)
EA (1) EA010913B1 (fr)
ES (1) ES2299090T3 (fr)
GE (1) GEP20115322B (fr)
HK (1) HK1107263A1 (fr)
HR (1) HRP20080107T3 (fr)
IL (1) IL182494A (fr)
IT (1) ITMI20041963A1 (fr)
MA (1) MA29007B1 (fr)
MX (1) MX2007004297A (fr)
NO (1) NO339805B1 (fr)
NZ (1) NZ554469A (fr)
PL (1) PL1799214T3 (fr)
PT (1) PT1799214E (fr)
RS (1) RS50563B (fr)
SI (1) SI1799214T1 (fr)
UA (1) UA86091C2 (fr)
WO (1) WO2006040004A1 (fr)
ZA (1) ZA200703009B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
WO2008046573A1 (fr) * 2006-10-16 2008-04-24 Grünenthal GmbH Dérivés de sulfonamide substitués en tant que modulateurs du récepteur de bradykinine-1
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
ITMI20072225A1 (it) * 2007-11-23 2009-05-24 Luso Farmaco Inst "composizioni farmaceutiche a base di antagonisti della bradichinina ed acido ialuronico e loro uso"
IT1391236B1 (it) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
WO2015155323A1 (fr) * 2014-04-10 2015-10-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagoniste du br2 destiné à être utilisé dans la prévention de l'effet hypotensif chez un patient traité avec des inhibiteurs de l'enzyme convertissant l'angiotensine (acei)
BR112019005167A2 (pt) * 2016-09-16 2019-07-02 Dyax Corp método e kit para analisar uma amostra
AU2018371186B2 (en) 2017-11-24 2022-05-12 Pharvaris Netherlands B.V. Novel bradykinin B2 receptor antagonists
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
WO2023180577A1 (fr) 2022-03-25 2023-09-28 Pharvaris Gmbh Utilisations thérapeutiques d'antagonistes du récepteur b2 de la bradykinine
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物
WO2023180575A1 (fr) 2022-03-25 2023-09-28 Pharvaris Gmbh Composition solide comprenant des antagonistes du récepteur b2 de la bradykinine solubilisés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP1741444A1 (fr) * 2005-07-05 2007-01-10 Jerini AG Antagonistes de kinine pour traiter le dysfonctionnement de la vessie

Also Published As

Publication number Publication date
IL182494A (en) 2011-07-31
JP2008516901A (ja) 2008-05-22
EP1799214A1 (fr) 2007-06-27
MX2007004297A (es) 2008-03-11
ZA200703009B (en) 2008-08-27
EA010913B1 (ru) 2008-12-30
ATE381931T1 (de) 2008-01-15
GEP20115322B (en) 2011-11-10
AU2005293881B2 (en) 2010-02-25
EP1799214B8 (fr) 2008-06-18
US7645759B2 (en) 2010-01-12
CN101039671B (zh) 2010-10-13
AU2005293881A1 (en) 2006-04-20
CY1107254T1 (el) 2012-11-21
IL182494A0 (en) 2007-09-20
DK1799214T3 (da) 2008-05-13
HRP20080107T3 (en) 2008-05-31
CA2583920A1 (fr) 2006-04-20
DE602005004039T2 (de) 2009-01-22
DE602005004039D1 (de) 2008-02-07
BRPI0515983A (pt) 2008-08-12
SI1799214T1 (sl) 2008-06-30
WO2006040004A1 (fr) 2006-04-20
AR051392A1 (es) 2007-01-10
US20070281944A1 (en) 2007-12-06
CA2583920C (fr) 2013-02-12
PT1799214E (pt) 2008-03-31
MA29007B1 (fr) 2007-11-01
UA86091C2 (ru) 2009-03-25
EA200700584A1 (ru) 2007-10-26
RS50563B (sr) 2010-05-07
EP1799214B1 (fr) 2007-12-26
NZ554469A (en) 2010-02-26
ES2299090T3 (es) 2008-05-16
ITMI20041963A1 (it) 2005-01-15
NO20071840L (no) 2007-04-11
CN101039671A (zh) 2007-09-19
NO339805B1 (no) 2017-02-06
JP4980917B2 (ja) 2012-07-18
PL1799214T3 (pl) 2008-05-30

Similar Documents

Publication Publication Date Title
HK1107263A1 (en) Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
EP1804823A4 (fr) Nouveaux analogues de la cyclosporine et leurs utilisations pharmaceutiques
IL223545A0 (en) Pharmaceutical compositions
IL179809A0 (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
ZA200702128B (en) Interleukin-15 antagonist peptide
TWI315983B (en) Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
PL1837019T3 (pl) Kompozycja farmaceutyczna rozpadająca się w ustach
IL183986A0 (en) Pharmaceutical compounds and compositions
IL178067A0 (en) Pharmaceutical dosage forms and compositions
EP1805154A4 (fr) Compositions pharmaceutiques
EP1796686A4 (fr) Antagonistes d'emmprin et leurs utilisations
EP1937292A4 (fr) Compositions pharmaceutiques a base de lopap et leurs utilisations
EP1828227A4 (fr) Nouveaux antagonistes peptidiques et peptidoïdes du recepteur de la bradykinine b1 et utilisations de ceux-ci
IL157398A0 (en) Pharmaceutical compositions comprising ccr5 antagonists
EP1747205A4 (fr) Compositions pharmaceutiques
GB0502792D0 (en) Pharmaceutical compositions
GB0411502D0 (en) Pharmaceutical compositions
GB0407351D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
GB0408301D0 (en) Pharmaceutical compositions
GB0412562D0 (en) Pharmaceutical compositions
GB0412733D0 (en) Pharmaceutical compositions
GB0420173D0 (en) Pharmaceutical compositions
GB0422572D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180927